Edition:
United Kingdom

Syndax Pharmaceuticals Inc (SNDX.OQ)

SNDX.OQ on NASDAQ Stock Exchange Global Select Market

8.03USD
15 Dec 2017
Change (% chg)

$-0.97 (-10.78%)
Prev Close
$9.00
Open
$8.90
Day's High
$8.98
Day's Low
$8.00
Volume
495,305
Avg. Vol
50,214
52-wk High
$15.65
52-wk Low
$6.38

Select another date:

Tue, Nov 7 2017

BRIEF-Syndax Pharmaceuticals reports Q3 loss per share $0.68

* Syndax pharmaceuticals reports third quarter 2017 financial results and provides clinical and business update

BRIEF-Syndax announces $25 million registered direct offering of common stock

* Syndax announces $25 million registered direct offering of common stock

BRIEF-Syndax Pharma enters into license agreement with unit of Allergan

* On Oct 13, co entered into license agreement with Vitae Pharmaceuticals, a subsidiary of Allergan Plc​ - SEC filing

BRIEF-‍Syndax announces dosing of first patient in trial of Entinostat for treatment of recurrent breast cancer

* ‍Syndax announces dosing of first patient in pivotal trial of entinostat for treatment of advanced or recurrent breast cancer in Japan by partner kyowa hakko kirin​

BRIEF-Syndax Pharmaceuticals Q2 loss per share $0.70

* Syndax Pharmaceuticals reports second quarter 2017 financial results and provides clinical and business update

Select another date: